Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK. 


Biotechnology

Education

Instil Bio

Bronson Crouch

Carol Castaneda

Jennifer Montoya

Artur Burgiel

Steve Dinnogen

Craig Kessler

T. David Chonzi

Sharon McGonagle

Film Sarah Turnbull Fcipd Fitol (Goodfellow)

Sandeep Laumas (Steve)

Robert Bob Hawkins

Mark Dudley

Sandeep Laumas

The Board & Executive Committee at Instil Bio oversees the strategic direction, governance, and financial performance of the company. Comprised of board members and top executives, including the CEO, CSO, and CFO, this team ensures alignment with corporate goals, regulatory compliance, and advancement of Instil Bio's clinical and research initiatives. They provide critical leadership in decision-making, risk management, and stakeholder engagement to drive the success of Instil Bio's cell therapy innovations in treating solid tumor cancers.

Board & Executive Committee

Research and Development

Finance Team

Board & Executive Committee

About

Team members

Other teams at Instil Bio

Research and Development

Finance Team